GlassScriptPhysician profile
Marcy L Smith
NPI 1629093067
$3,221.09
in general payments reported to CMS, 2019-2025
16 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $596 · 2022: $757 · 2023: $603 · 2024: $796 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Education: $84.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.89 |
| Education | $84.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $876.38 | 2021-2024 | Cardiomems |
| Novo Nordisk INC | $433.77 | 2022-2025 | Ozempic, Wegovy |
| Scpharmaceuticals INC. | $359.74 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $263.40 | 2022-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $195.84 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $160.43 | 2024-2025 | Camzyos, Eliquis |
| Abiomed | $158.69 | 2022 | |
| Cvrx, INC. | $133.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $132.36 | 2021 | |
| Impulse Dynamics (USA) INC. | $128.65 | 2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $125.95 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.85 | 2023 | Jardiance |
| Amgen INC. | $73.97 | 2024-2025 | Repatha, Repatha |
| Lexicon Pharmaceuticals, INC. | $50.13 | 2024 | |
| Siemens Medical Solutions USA, INC. | $22.12 | 2024 | Artis Icono Floor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $20.78 | 2025 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.